Holen Sie sich die Stockscreener-App
4.45
2.88%
0.105
Handel nachbörslich:
4.35
-0.10
-2.25%
Schlusskurs vom Vortag:
$4.345
Offen:
$4.26
24-Stunden-Volumen:
2.50M
Relative Volume:
0.53
Marktkapitalisierung:
$1.06B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-252.18M
KGV:
-4.1981
EPS:
-1.06
Netto-Cashflow:
$-185.29M
1W Leistung:
+8.50%
1M Leistung:
+38.82%
6M Leistung:
+146.96%
1J Leistung:
+11.47%
1-Tages-Spanne:
$4.21
$4.64
1-Wochen-Bereich:
$4.10
$4.82
52-Wochen-Spanne:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.45 | 1.12B | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Wedbush | Outperform |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
Will Sana Biotechnology Inc. stock outperform tech sector in 2025July 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Real time breakdown of Sana Biotechnology Inc. stock performanceJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Will Sana Biotechnology Inc. stock maintain momentum in 2025Quarterly Performance Summary & Technical Pattern Based Signals - newser.com
Comparing Sana Biotechnology Inc. in custom built stock radars2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Real time alert setup for Sana Biotechnology Inc. performance2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Is Sana Biotechnology Inc. a candidate for recovery playQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsJuly 2025 Setups & Verified Technical Signals - newser.com
How to escape a deep drawdown in Sana Biotechnology Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Visualizing Sana Biotechnology Inc. stock with heatmapsQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
Sana Biotechnology (SANA): Evaluating Valuation Following Recent 47% Share Price Surge - Yahoo Finance
Sana Biotechnology's (SANA) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to build a dashboard for Sana Biotechnology Inc. stockGold Moves & Risk Controlled Stock Alerts - newser.com
Statistical indicators supporting Sana Biotechnology Inc.’s strength2025 Year in Review & Stock Portfolio Risk Control - newser.com
Evaluating Sana Biotechnology (SANA): Is Recent Momentum Reflected in Its Current Valuation? - Sahm
Sana Biotechnology (NASDAQ:SANA) Trading 9.1% HigherShould You Buy? - MarketBeat
Is a relief rally coming for Sana Biotechnology Inc. holdersTreasury Yields & AI Powered Market Entry Ideas - newser.com
Visual analytics tools that track Sana Biotechnology Inc. performanceJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Combining price and volume data for Sana Biotechnology Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Does Sana Biotechnology Inc. show high probability of reboundJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com
What data driven models say about Sana Biotechnology Inc.’s futureNew Guidance & Verified Momentum Stock Watchlist - newser.com
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Sector ETF performance correlation with Sana Biotechnology Inc.Bear Alert & Verified Trade Idea Suggestions - newser.com
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $7.50 Consensus Price Target from Brokerages - Defense World
Real time pattern detection on Sana Biotechnology Inc. stockQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sana Biotechnology Inc-Aktie (SANA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):